Additional file 3 of Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity

Additional file 3: Fig. S1. Flow cytometry gating strategy. Fig. S2. Leukemia associated immunophenotypes (LAIPs). Fig. S3. Gene set enrichment analysis (GSEA) and FOXM1 correlation analyses in post-chemotherapy blasts. Fig. S4. FOXM1 KD in AML cell lines. Fig. S5. FOXM1 knockdown in primary AML and normal CD34+ HSPCs. Fig. S6. FOXM1 inhibition in primary AML and normal CD34+ HSPCs.